Answers are grounded in this paper and cite their sources.
Meta-analysis shows reduced 28-day mortality and lower heart rates in sepsis patients receiving beta-blockers, suggesting improved clinical and hemodynamic outcomes.
This meta-analysis is to systematically evaluate the efficacy and safety of beta-blockers in the treatment of sepsis. A total of 17 articles that met the inclusion criteria were included, and 10,385 cases were obtained. The meta-analysis results showed that patients with sepsis with beta-blocker usage had a significantly lower 28-day mortality. The heart rate decreased over time in patients with sepsis using beta-blocker. Moreover, central venous blood oxygen saturation increased after 24, 48, 72 hours of treatment; lactic acid and cardiac troponin I decreased after 48, 72 hours of treatment; and tumor necrosis factor-α, interleukin-1β levels decreased significantly after 12, 24, 48, 72 hours of treatment (p<0.05). In conclusion, beta-blockers reduce 28-day mortality and heart rate.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: